The present invention relates to Fms-like tyrosine kinase (FLT3) inhibitors. The present invention provides novel 4-quinolinone derivatives used as FLT3 inhibitors and for treatment and/or prevention of tumors.
Thiochromeno[2,3-c]quinolin-12-one derivatives and their use as topoisomerase inhibitors
申请人:National Defense Medical Center
公开号:EP3002287B1
公开(公告)日:2018-01-31
FMS-LIKE TYROSINE KINASE INHIBITORS
申请人:3SM BIOTRON INC.
公开号:US20200131194A1
公开(公告)日:2020-04-30
The present invention relates to Fms-like tyrosine kinase (FLT3) inhibitors. The present invention provides novel 4-quinolinone derivatives used as FLT3 inhibitors and for treatment and/or prevention of tumors.